Sowell Financial Services’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$622K Sell
3,231
-21
-0.6% -$2.26K 0.02% 585
2026
Q2
$228K Buy
+3,252
New +$168K 0.01% 1003
2021
Q2
– Sell
-2,178
Closed -$350K – 1891
2021
Q1
$350K Sell
2,178
-508
-19% -$73.6K 0.01% 775
2020
Q4
$281K Sell
2,686
-104
-4% -$10.5K 0.01% 721
2020
Q3
$197K Buy
2,790
+655
+31% +$45.7K 0.01% 733
2020
Q2
$137K Buy
2,135
+49
+2% +$2.68K 0.01% 864
2020
Q1
$62K Sell
2,086
-1,466
-41% -$33.7K ﹤0.01% 979
2019
Q4
$69K Buy
+3,552
New +$63K 0.01% 1035

Other funds holding MRNA

Sowell Financial Services's MRNA Position: Q3 2026 in Review

Sowell Financial Services reduced its Moderna (MRNA) stake by 0.65% in Q3 2026, selling an estimated $2.26K and leaving 3,231 shares worth $622K. The position accounts for 0.02% of the portfolio, ranked #585.

Sowell Financial Services first reported a position in MRNA in Q4 2019 and has held it in 8 quarters since. 615 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Sowell Financial Services held 3,231 shares of Moderna worth $622K as of Q3 2026.
  • Sowell Financial Services sold 21 Moderna shares in Q3 2026, an estimated $2.26K.
  • Moderna made up 0.02% of Sowell Financial Services's portfolio in Q3 2026, its #585 holding.
  • Sowell Financial Services first reported a position in Moderna in Q4 2019 and has held it in 8 quarters since.
  • 615 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Sowell Financial Services's 13F filing for Q3 2026, filed 20 Oct 2026.